Fig. 3From: Ruxolitinib treatment permits lower cumulative glucocorticoid dosing in children with secondary hemophagocytic lymphohistiocytosisMean body temperature of the two groups. Body temperature returned to normal after 3 days of ruxolitinib treatment. The mean body temperature of group R patients was lower than that of group C patientsBack to article page